Proteogenomic decoding of chemotherapy resistance in patients with triple-negative breast cancer
{{output}}
Background: The clinical utility of integrated proteogenomic biomarkers for predicting chemotherapy response in triple-negative breast cancer remains underexplored. We prospectively analyzed paired baseline and post-treatment tum... ...
